Home / Crime and Justice / Sackler Family to Contribute $7 Billion in Opioid Crisis Deal
Sackler Family to Contribute $7 Billion in Opioid Crisis Deal
28 Apr
Summary
- Purdue admitted to lacking an effective plan to prevent opioid diversion.
- Settlement includes up to $7 billion from the Sackler family over 15 years.
- Individual victims may receive $8,000 to $16,000 from the settlement.

Purdue Pharma is nearing the finalization of a substantial settlement to resolve legal actions related to the opioid crisis. The company admitted to deficiencies in its program designed to prevent the diversion of prescription painkillers to the illicit market. As part of the agreement, members of the owning Sackler family are slated to contribute up to $7 billion over a 15-year period.
The settlement includes provisions for payments to individual victims, which are anticipated to range from approximately $8,000 to $16,000. The bulk of the settlement funds are earmarked for government entities to support efforts in combating the opioid crisis, which has been linked to over 900,000 deaths in the U.S. since 1999.